Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Dr. Xudong Huang has received his PhD degree from Massachusetts Institute of Technology (MIT) and completed postdoctoral training at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS). He is the Co-Director of Neurochemistry Lab, Psychiatry Department of MGH, a world leading hospital. He has published more than 100 papers in reputed journals and has been serving as the Editor-in-Chief for the International Journal of Biomedical Nanoscience and Nanotechnology (IJBNN). In addition, Dr. Huang has served as a manuscript reviewer for more than 50 research journals and a grant reviewer for private foundations and government agencies including Alzheimer’s Association, American Federation for Aging Research (AFAR), and NIH.
Nanoneurotoxicity and its potential link to brain disorders such as Alzheimer’s and Parkinson’s diseases, ALS, and depression. Novel applications of nanotechnology. Dr. Huang’s major research activities and achievements are centered upon: (i) validating potential correlation of environmental stressors such as exposure of metals and metal oxide nanoparticles with neurodegeneration using in vivo molecular imaging modalities; (ii) CNS drug discovery initiatives using artificial intelligence (AI)-based computer screening and cell-based high throughput screening (HTS) techniques; (iii) exploring novel biomedical big data analytics in gene expression clustering and MRI data classification using clinical data, machine learning (ML) methods such as support vector machine (SVM), etc., and deep learning (DL) algorithms such as convolution neural network (CNN).